Literature DB >> 381082

Glucagon and diabetes: a reappraisal.

P J Lefebvre, A S Luyckx.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 381082     DOI： 10.1007/bf01223153

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  67 in total

1.  Demonstration of gastric glucagon hypersecretion in insulin-deprived alloxan-diabetic dogs.

Authors:  E Blazquez; L Muñoz-Barragan; G S Patton; R E Dobbs; R H Unger
Journal:  J Lab Clin Med       Date:  1977-05

2.  Plasma glucagon and clinical control of maturity-onset type diabetes. Effects of diet, placebo and glipizide.

Authors:  M J Lecomte; A S Luyckx; P J Lefebvre
Journal:  Diabete Metab       Date:  1977-12

3.  Glucose suppression of glucagon: relationship to pancreatic beta cell function?

Authors:  H H Hatfield; M F Banasiak; T Driscoll; H J Kim; R K Kalkhoff
Journal:  J Clin Endocrinol Metab       Date:  1977-06       Impact factor: 5.958

4.  Stimulatory effects of prostaglandins E-1, E-2, and F-2-alpha on glucagon and insulin release in vitro.

Authors:  S Pek; T Y Tai; A Elster
Journal:  Diabetes       Date:  1978-08       Impact factor: 9.461

5.  24-hour studies of the effects of somatostatin on the levels of plasma growth hormone, glucagon, and glucose in normal subjects and juvenile diabetics.

Authors:  S E Christensen; A P Hansen; J Weeke; K Lundbaek
Journal:  Diabetes       Date:  1978-03       Impact factor: 9.461

6.  Glucagon: role in the hyperglycemia of diabetes mellitus.

Authors:  R Dobbs; H Sakurai; H Sasaki; G Faloona; I Valverde; D Baetens; L Orci; R Unger
Journal:  Science       Date:  1975-02-14       Impact factor: 47.728

7.  Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects.

Authors:  R S Sherwin; M Fisher; R Hendler; P Felig
Journal:  N Engl J Med       Date:  1976-02-26       Impact factor: 91.245

8.  Ketoacidosis in pancreatectomized man.

Authors:  A J Barnes; S R Bloom; K Goerge; G M Alberti; P Smythe; F P Alford; D J Chisholm
Journal:  N Engl J Med       Date:  1977-06-02       Impact factor: 91.245

9.  Salivary gland hyperglycemic factor: an extrapancreatic source of glucagon-like material.

Authors:  A M Lawrence; S Tan; S Hojvat; L Kirsteins
Journal:  Science       Date:  1977-01-07       Impact factor: 47.728

10.  Glucagon secretion from the perfused pancreas of streptozotocin-treated rats.

Authors:  G C Weir; S D Knowlton; R F Atkins; K X McKennan; D B Martin
Journal:  Diabetes       Date:  1976-04       Impact factor: 9.461
View more
  12 in total

1.  Indirect effect of insulin to suppress endogenous glucose production is dominant, even with hyperglucagonemia.

Authors:  S D Mittelman; Y Y Fu; K Rebrin; G Steil; R N Bergman
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

Review 2.  Pulsatility of insulin and glucagon release: physiological significance and pharmacological implications.

Authors:  P J Lefèbvre; G Paolisso; A J Scheen; J C Henquin
Journal:  Diabetologia       Date:  1987-07       Impact factor: 10.122

3.  Effects of guar on plasma viscosity and related parameters in diabetic children.

Authors:  P Koepp; S Hegewisch
Journal:  Eur J Pediatr       Date:  1981-09       Impact factor: 3.183

4.  Mammalian pancreatic preproglucagon contains three glucagon-related peptides.

Authors:  L C Lopez; M L Frazier; C J Su; A Kumar; G F Saunders
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

5.  Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM.

Authors:  S Dinneen; A Alzaid; D Turk; R Rizza
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

6.  Abnormal glucagon response to arginine and its normalization in obese hyperinsulinaemic patients with glucose intolerance: importance of insulin action on pancreatic alpha cells.

Authors:  T Hamaguchi; H Fukushima; M Uehara; S Wada; T Shirotani; H Kishikawa; K Ichinose; K Yamaguchi; M Shichiri
Journal:  Diabetologia       Date:  1991-11       Impact factor: 10.122

7.  Intermediate acting insulin given at bedtime: effect on blood glucose concentrations before and after breakfast.

Authors:  A J Francis; P D Home; I Hanning; K G Alberti; W M Tunbridge
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-09

8.  Effect of indomethacin on the metabolic and hormonal response to a standardized breakfast in normal subjects.

Authors:  A S Luyckx; D Guerten; A Scheen; J P Delporte; P J Lefebvre; F Jaminet
Journal:  Acta Diabetol Lat       Date:  1981 Jul-Sep

9.  Failure of indomethacin to affect arginine-induced C-peptide and glucagon release in insulin-treated diabetics. Major role of residual B cell function in conditioning the magnitude of the blood glucose rise after intravenous arginine.

Authors:  A S Luyckx; E Mendoza; P J Lefebvre
Journal:  Diabetologia       Date:  1981-10       Impact factor: 10.122

10.  The acute metabolic effects of glucagon and its interactions with insulin in forearm tissue.

Authors:  S H Schneider; S E Fineberg; G L Blackburn
Journal:  Diabetologia       Date:  1981-06       Impact factor: 10.122
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.